The heritage of glatiramer acetate and its use in multiple sclerosis-Reference-Cited by-同舟云学术

The heritage of glatiramer acetate and its use in multiple sclerosis

Published:2016-07-04 Issue:1 Volume:1 Page:
ISSN:2056-6115
Container-title:Multiple Sclerosis and Demyelinating Disorders
language:en
Short-container-title:Mult Scler Demyelinating Disord

Author:

Comi Giancarlo,Amato Maria Pia,Bertolotto Antonio,Centonze Diego,De Stefano Nicola,Farina Cinthia,Gallo Paolo,Ghezzi Angelo,Grimaldi Luigi Maria,Mancardi Gianluigi,Marrosu Maria Giovanna,Montanari Enrico,Patti Francesco,Pozzilli Carlo,Provinciali Leandro,Salvetti Marco,Tedeschi Gioacchino,Trojano Maria

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40893-016-0010-2

Reference116 articles.

1. Nylander A, Hafler DA. Multiple sclerosis. J Clin Invest. 2012;122(4):1180–8. doi: 10.1172/JCI58649 .

2. Lublin FD. New multiple sclerosis phenotypic classification. Eur Neurol. 2014;72 Suppl 1:1–5. doi: 10.1159/000367614 .

3. Cohen JA, Rae-Grant A. Handbook of Multiple Sclerosis. 2nd ed. London: Springer Healthcare; 2012.

4. Richards RG, Sampson FC, Beard SM, Tappenden P. A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models. Health Technol Assess. 2002;6(10):1–73.

5. Abramsky O, Teitelbaum D, Arnon R. Effect of a synthetic polypeptide (COP 1) on patients with multiple sclerosis and with acute disseminated encephalomeylitis. Preliminary report. J Neurol Sci. 1977;31(3):433–8.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple Sclerosis: Current Knowledge of the Pathology and Use of Monoclonal Antibodies as a Promising Therapy;Borneo Journal of Pharmacy;2023-11-30

2. Quality of life in people with multiple sclerosis receiving glatiramer acetate or interferon in Greek clinical practice;Neurodegenerative Disease Management;2022-12

3. Therapeutic Plants with Immunoregulatory Activity and Their Applications: A Scientific Vision of Traditional Medicine in Times of COVID-19;Journal of Medicinal Food;2022-12-01

4. Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice;International Journal of Nanomedicine;2022-09

5. Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study;Multiple Sclerosis Journal;2022-06-29